Major Bank Rating | Baird: Initiates Abbott with an "Outperform" rating and a target price of $121
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, July 3 — Baird has initiated research coverage of Abbott Laboratories, giving it an “Outperform” rating and setting a target price of $121. According to Baird, this diversified healthcare company is likely to achieve stronger earnings growth thanks to its broad product portfolio and upcoming product launches, despite facing some short-term headwinds.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Strategy founder Michael Saylor voices opposition to BIP 110
金色财经•2026/07/18 22:54
French Hill: The CLARITY Act is the most important ethics regulation legislation in Congress
AiCoin•2026/07/18 21:46
ARK: SpaceX is No Longer Just a Rocket Company
Cointime•2026/07/18 21:20
Crypto prices
More
Bitcoin
BTC
$64,747.84
+1.26%
Ethereum
ETH
$1,862.28
+1.29%
Tether USDt
USDT
$0.9993
-0.00%
USDC
USDC
$0.9999
-0.00%
XRP
XRP
$1.09
+0.52%
Solana
SOL
$75.49
+0.71%
TRON
TRX
$0.3258
+0.98%
Hyperliquid
HYPE
$60.49
+1.09%
Dogecoin
DOGE
$0.07243
-0.12%
Zcash
ZEC
$560.19
+3.16%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now